SCCM is performing maintenance on its websites. For the best browsing experience, please use Microsoft Edge or Safari. Those using Chrome or Firefox may experience access issues at this time.

SCCM Pod-203 PCCM: Using the Vanguard Phase in Clinical Trials

visual bubble
visual bubble

Margaret Parker, MD, FCCM, speaks with Victoria L. Pemberton, RN, MS, about her article published in the January Pediatric Critical Care Medicine titled, "Therapeutic Hypothermia After Pediatric Cardiac Arrest Trials: The Vanguard Phase Experience and Implications for Other Trials." The use of an 18-month vanguard phase in the Therapeutic Hypothermia After Cardiac Arrest Trials was beneficial to both investigators and the funding agency, allowing time to refine the protocol for feasibility and safety as well as time to complete administrative activities. Pemberton is a clinical trials specialist at The National Heart, Lung, and Blood Institute in Bethesda, Maryland.

*If you are unable to play the podcast please click here to download the file.

Category: PCCM Podcast



Knowledge Area: Research